Kaneka is a global leader in biotechnology, with significant capabilities in manufacturing APIs. The company specializes in the production of complex, high-value APIs, leveraging cutting-edge fermentation and chemical synthesis technologies. Kaneka's four manufacuring sites — located in Japan and Singapore — offer expertise in chiral chemistry, enzymes, and the production of high-potency APIs (HPAPIs), serving both small- and large-scale pharmaceutical needs.